spontaneous intracerebral hemorrhage
Conditions
Interventions
Group A1:Without surgical treatment and without taking Naoxueshu oral liquid
Group A2:After surgical treatment but did not take Naoxueshu oral liquid.
Group B1:Take Naoxueshu oral liquid without surgical treatment
Group B2:After surgical intervention and taking Naoxueshu oral liquid
Sponsors
North China University of Science and Technology Affiliated Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients who were confirmed by magnetic resonance imaging ((MRI)) and computerized tomography ((CT)) and met the criteria for the diagnosis and treatment of SICH approved in the AHA/ASA guidelines were selected; 2. The amount of supratentorial bleeding <= 30ml, the displacement of midline does not exceed 5mm, and the amount of subependental bleeding <= 10ml; 3. Aged 18 to 80 years; 4. Select SICH patients within one week of onset; 5. The NIHSS score is between 2 and 20; 6. Obtain the informed consent of the patient.
Exclusion criteria
Exclusion criteria: 1. Patients with severe dysarthria, hearing impairment, cognitive impairment and other reasons cannot cooperate with the scale assessment; 2. Patients with loss of consciousness and disturbance of consciousness; 3. Due to the insufficiency of important organs such as the heart, liver and kidney, the researchers believe that they are not suitable to participate in this researcher; 4. Patients with severe mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Volume of hematomas;Severity of brain edema;Serious adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver function;Renal function;Coagulation function;Neural function evaluation;Blood routine; | — |
Countries
China
Contacts
Public ContactChen Tong
North China University of Science and Technology Affiliated Hospital
Outcome results
None listed